Semaglutide

5mg · Lyophilized Powder · 4,113.58 Da

VIAL SIZE

$45.00 CAD

Semaglutide is a GLP-1 receptor agonist peptide with an extended half-life of approximately 168 hours, enabling once-weekly subcutaneous administration. Studied extensively in Phase 3 trials, it modulates appetite signalling through the hypothalamus while slowing gastric emptying and improving postprandial glucose disposal. Research demonstrates dose-dependent reductions in body weight alongside improvements in cardiovascular risk markers at clinical doses up to 2.4 mg weekly. Its acylation chemistry enables high albumin binding for sustained systemic exposure.

Research Applications

•Appetite and energy intake modulation via GLP-1 receptor activation

•Chronic body weight reduction in metabolic research models

•Postprandial glucose and insulin response regulation

•Cardiovascular risk marker improvement in metabolic syndrome models

•Gastric emptying rate modulation and satiety signalling research

•HbA1c reduction in type 2 diabetes research protocols

VIAL5 / 8 / 11 / 15 / 20 / 30 mg

PURITY≥99% (HPLC)

FORMLyophilized powder

STORAGE-20°C lyophilized / 2-8°C reconstituted

RECON2.0 mL BAC water (5mg vial)

USEResearch only

VIEW DOSING PROTOCOL →

All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.